CYP1A1 and lung carcinoma: Our study included 8 SNPs from the CYP1A1/A2 region not previously studied in case-control studies of lung cancer, and some of these SNPs were not included in the platforms used for recent genome-wide association studies (GWAS) [20]–[24].